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Improving the yeast two-hybrid system with
permutated fusions proteins: the Varicella Zoster
Virus interactome
Thorsten Stellberger1, Roman Häuser1, Armin Baiker2, Venkata R Pothineni2, Jürgen Haas2,3, Peter Uetz1,4*
Abstract
Background: Yeast two-hybrid (Y2H) screens have been among the most powerful methods to detect and analyze
protein-protein interactions. However, they suffer from a significant degree of false negatives, i.e. true interactions
that are not detected, and to a certain degree from false positives, i.e. interactions that appear to take place only in
the context of the Y2H assay. While the fraction of false positives remains difficult to estimate, the fraction of false
negatives in typical Y2H screens is on the order of 70-90%. Here we present novel Y2H vectors that significantly
decrease the number of false negatives and help to mitigate the false positive problem.
Results: We have constructed two new vectors (pGBKCg and pGADCg) that allow us to make both C-terminal
fusion proteins of DNA-binding and activation domains. Both vectors can be combined with existing vectors for N-
terminal fusions and thus allow four different bait-prey combinations: NN, CC, NC, and CN. We have tested all
~4,900 pairwise combinations of the 70 Varicella-Zoster-Virus (VZV) proteins for interactions, using all possible
combinations. About ~20,000 individual Y2H tests resulted in 182 NN, 89 NC, 149 CN, and 144 CC interactions.
Overlap between screens ranged from 17% (NC-CN) to 43% (CN-CC). Performing four screens (i.e. permutations)
instead of one resulted in about twice as many interactions and thus much fewer false negatives. In addition,
interactions that are found in multiple combinations confirm each other and thus provide a quality score. This
study is the first systematic analysis of such N- and C-terminal Y2H vectors.
Conclusions: Permutations of C- and N-terminal Y2H vectors dramatically increase the coverage of interactome
studies and thus significantly reduce the number of false negatives. We suggest that future interaction screens
should use such vector combinations on a routine basis, not the least because they provide a built-in quality score
for Y2H interactions that can provide a measure of reproducibility without additional assays.
Background
The yeast two-hybrid (Y2H) system has been among the
most powerful methods to identify protein-protein inter-
actions. However, it has also been criticized for generat-
ing large numbers of false positive and false negative
data. While false positives can be minimized by includ-
ing controls, retesting by independent methods, and
bioinformatic filtering, false negatives pose a much big-
ger problem. In fact, many interactions must go unde-
tected in two-hybrid screens because of the sterical
constraints the system involves: the two fusion proteins
must interact with each other, their interaction
interfaces must be exposed, and all components must be
oriented on the DNA in a way that the activation
domain of the prey can productively interact with the
transcriptional machinery.
On top of sterical constraints, small variations of the
Y2H system can lead to large differences in resulting
interactions [1]. As no other large-scale screen has used
multiple Y2H systems, not much attention has been
paid to this phenomenon. Here we investigate such
multi-system screens to characterize the interactome of
Varicella-Zoster Virus (VZV). While many smaller
viruses and their interactions have been studied, larger
viruses have been analyzed only recently [2,3]. The five
herpesviruses studied by Fossum et al. (i.e. HSV1, EBV,
mCMV, VZV, KSHV) have been the only herpesviruses
* Correspondence: uetz@jcvi.org
1Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, PO
Box 3640, D-76021 Karlsruhe, Germany
Stellberger et al. Proteome Science 2010, 8:8
http://www.proteomesci.com/content/8/1/8
© 2010 Stellberger et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
studied systematically for pairwise intraviral interactions
[4]. However, we also know that the few studies that
have been done resulted in markedly different interac-
tions. For example, two systematic screens of protein-
protein interactions among proteins of Kaposi-Sarcoma
Herpesvirus (KSHV) yielded very little overlap [5,6].
Clearly, slight variations of vectors, strains, or assay con-
ditions can strongly affect the resulting interactions,
even when identical proteins are used.
Here we present new vectors that vary one parameter
of Y2H screening, namely the location of the Gal4
DNA-binding (DBD) and activation domain (AD) (Fig-
ures 1 and 2). Traditionally, Y2H vectors carry their
cloning sites C-terminal of their DBD and AD so that
the bait and prey proteins are fused C-terminally to
these domains. Several vectors have been described that
use C-terminal fusions of AD and DBDs (e.g. [7-10]).
These studies have shown that the location of the fusion
site is critical when selected protein pairs were tested (e.
g. [7]). However, previously made vectors are not easily
compatible with high-throughput cloning because they
require conventional restriction digests and cloning. As
a consequence, it remained unclear how N- or C-term-
inal fusions compare when larger sets of proteins or
whole genomes are analyzed in standardized Y2H assays.
Results
Interactions resulting from different vectors
Each of the four bait/prey vector combinations pro-
duced significantly different interactions. For example,
the screens with bait ORF19, the large subunit of ribo-
nucleotide reductase, produced a total of 17 interactions
(of 15 distinct proteins), of which only two were found
in all four combinations (namely ORF25 and ORF18C)
(Figure 3A). Five interactions were found with the N-
terminal fusions (in pGBKT7g and pGADT7g) while 11
(3 strong + 8 weak) interactions resulted from the
screens with the C-terminal fusions (in pGBKCg and
pGADCg). The CN and NC combinations generated 7
and 8 interactions, respectively.
The interactions detected also depended strongly on
the selection pressure: typically all screens were initially
carried out without 3-aminotriazole (3AT), a competi-
tive inhibitor of imidazoleglycerolphosphate (IGP) dehy-
dratase, i.e. the His3 reporter enzyme used in our
assays. If baits turned out to be autoactivating under
these conditions, we raised the 3AT concentrations up
to 50 mM in steps of 1, 3, 10, 25, and 50 mM. ORF19
was an activator at 0, 1, and 3 mM and clear results
were only obtained at 10 or 25 mM (Figure 3). Most
interactions disappeared at 25 mM (Figure 3B). In gen-
eral, the results reported here were obtained at a 3AT
concentration that clearly differentiated between signal
and noise. Note that ORF19 was an activator as an N-
terminal DBD-fusion but not as a C-terminal fusion
(background in Figure 3A). However, this was not gen-
erally true: in 20 cases the N-terminal bait fusion auto-
activated while 21 of the C-terminal baits did so. In 7
cases both fusions were autoactivators at 3 mM 3AT or
higher concentrations but only one (ORF46) required
more than 3 mM in both cases and was thus not inter-
pretable (data not shown).
Overlap between vector combinations
Altogether, we have conducted more than 20,000 indivi-
dual Y2H tests (96 × 96 pairwise combinations for each
of the four permutations including multiple constructs
for 18 proteins, see Table 1 and Additional file 1: Table
S4). As shown in Figure 3 different vector combinations
produced non-overlapping results. This was generally
true (Figure 4): while the N-terminal fusions produced a
total of 182 interactions, only 15 of them were also
found with the other three combinations (Figure 4). 115
interactions were exclusively found with the N-terminal
combination. No combination turned out to be superior
to the other three although the number of NC pairs was
somewhat lower (89) than the NN, CN, and CC pairs
(ranging from 144 to 182, Figure 4). Overall, adding
three additional combinations to any of the four
increased the number of additional interactions by 2.2
to 4.5-fold (Additional file 1: Table S3).
Reduction of false negatives
In order to evaluate how well our new vectors prevented
false negatives we compared our data to published data.
First, we used a literature-curated dataset of herpesviral-
interactions [4]. Since not many VZV interactions have
been published in small-scale studies that can serve as
gold-standards we included small-scale interactions
from other herpesviruses as well and checked whether
we find interologs of these interactions (see Methods for
definitions of interologs and literature-curated interac-
tions). Fossum et al. [4] listed 91 such literature-curated
interactions from five different herpesviruses including 9
in VZV. 67 of the 91 interacting pairs had both ortho-
logs in VZV. Each of the four vector combinations
found an average of 5.75 interactions out of these 67 (=
8.6%; Additional file 1: Table S3D). When data from 2,
3, or all 4 vector combinations is pooled, we detect 13.7,
17.5, and 21% of these interactions (Figure 5A). That is,
the use of all four vectors more than doubled the num-
ber of known interactions detected. While 21% does not
sound very impressive, one has to keep in mind that
these are interologs. We do not expect that all interac-
tions are conserved across all herpesviruses, so that
much lower numbers are expected.
Similarly, we asked how many of 166 Y2H interactions
found among core proteins of HSV1, mCMV, EBV, or
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KSHV are found in at least one of our 4 vector combi-
nations (core proteins are those proteins that are con-
served in all 5 viruses). Again, given that not all
interactions are conserved, we do not expect to find all
of these interactions. If single screens are performed (i.e.
with only one of the 4 vector pairs) we find 14% of
these core interactions on average (Figure 5B, Additional
file 1: Table S3E). However, if we use all four vector
combinations, this fractions more than doubles to 31%
or 51 interactions. This clearly demonstrates that the
use of multiple fusion proteins can significantly reduce
the number of false negatives in Y2H screens.
Reduction of false positives
It is almost impossible to prove the existence of false
positives, especially for viral proteins that are known to
be expressed in the same cell. We simply cannot know
for sure that interactions detected in a Y2H assay do
not happen in a human host cell. Thus we provide only
circumstantial evidence that interactions found in multi-
ple combinations are of higher quality than interactions
found in a single screen. We looked at interactions that
we found in one, two, three, or four combinations and
then determined the fraction of these subsets that have
been confirmed by either literature curated interologs,
Y2H interologs, or independent Y2H assays. The latter
include cases in which an interaction is found with dif-
ferent protein fragments, e.g. the interaction shown in
Figure 3 involves ORF18 as well as ORF18C which is a
C-terminal fragment of ORF18. We believe that interac-
tions found with multiple protein fragments support
this interaction (as long as the fragments are not exclu-
sive as in non-overlapping N- and C-terminal frag-
ments). Figure 5C shows that the number of
combinations that an interaction was found in is directly
correlated with the level of confirmation. That is, the
Figure 1 Vectors described in this study including their parental vectors. pGBKT7g and pGADT7g generate N-terminal fusions of DNA-
binding (DBD) and activation domain (AD) fusions, respectively. The new vectors pGBKCg and pGADCg fuse DBD and AD at the C-terminus of
inserted ORFs. Note that both pGBK vectors use a truncated version of the ADH promoter (indicated by *) which may reduce expression levels
and thus interaction signals [26,27].
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Figure 2 Cloning sites and fusion products. (A) pGBKCg generates a C-terminal fusion of the Gal4 DBD separated by a 13 amino acid linker
from the N-terminally fused ORF (here: VZV ORF 19). A MYC tag is embedded in a C-terminal 37 amino acid tail. (B) pGADCg generates a C-
terminal fusion of the Gal4 AD. The cloned ORF (here: VZV ORF 26) is preceded by a 33 amino acid sequence that contains the nuclear
localization signal (NLS). The NLS of pGBKC is part of the DBD. A 14 amino acid linker separates the ORF from the Gal4 AD. The HA tag of
pGADCg has been shortened to seven amino acids so that it may not be recognized by anti-HA antibodies. During the LR reaction the Gateway
cassette in both vectors will be replaced by the sequence of interest plus additional nucleotides from the entry clone (i.e. the underlined
sequence will be replaced). For further technical details see the Gateway manuals at http://www.invitrogen.com. pGBKCg and pGADCg have
been deposited with and are available from Addgene http://www.addgene.com. Their sequences have been deposited with GenBank under
accession numbers FJ696409 (pGBKCg) and FJ696408 (pGADCg). pGBKT7g and pGADT7g are available from the authors.
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Figure 3 N- and C-terminal vectors detect different interactions. Y2H screens of the four different vector combinations showing the
differences on 3 mM (A) and 25 mM 3AT (B). The same bait, ORF19 (Uniprot accession P09248) was used as bait with N-terminally and C-
terminally fused DNA-binding and activation domains and screened against a whole-genome array of Varicella Zoster Virus (VZV). The N-terminal
bait and prey constructs (in pGBKT7g, pGADT7g, NN) show markedly different interaction patterns compared to the C-terminal constructs cloned
into pGBKCg and pGADCg (CC). NC and CN combinations show yet different interactions. Preys are indicated by their ORF number, e.g. the bait
ORF19 is the large ribonucleotide reductase (RNR) subunit which is known to interact with itself and the small RNR subunit (ORF18 = Uniprot
P09247). Note that N and C labels near yeast colonies indicate N- and C-terminal protein fragments, not AD or DBD fusions (e.g. 18C and 18N
are N- and C-terminal domains of ORF18). A complete list of interactions is provided in Additional file 1: Table S1. The sequences of all proteins
are listed in Additional file 1: Table 4.
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more combinations an interaction is found with, the
more likely it is to be found in our literature-curated
gold standard dataset, among a set of interologs, or
among additional constructs. In other words: if an inter-
action is found in two or more combinations it is less
likely to be a false positive.
Which vector combination is best?
We wondered whether any of the four permutations was
superior to the other ones. Surprisingly, this does not
seem to be the case. The fraction of validated interac-
tions (based on interologs and validating alternative con-
structs) in all cases ranges from 45% to 50% (Additional
file 1: Table S3C).
Discussion
The main problem of Y2H screens is the high rate of
false negatives [11,12] and new vector systems as the
one shown here may alleviate that problem. We have
shown recently that alternative N-terminal vector sys-
tems can reduce the number of false positives and this
study extends this finding to C-terminal fusions and
combinations with N-terminal vectors.
Expression levels of bait and prey proteins
Results of Y2H assays may be affected by the expression
levels of bait and prey proteins, e.g. if one or both are
inefficiently translated or if the proteins themselves are
unstable. We have not tested the expression levels of
the various N- and C-terminal fusion proteins used here
but we believe that their expression levels are similar or
at least sufficient for several reasons. Most importantly,
we get similar numbers of interactions with N- and C-
terminal fusion proteins, indicating that they both form
functional (or at least interacting) proteins, even if the
NC combination yielded a significantly lower number of
interations than the CN combination.
Independent confirmation
Two-hybrid interactions have often been considered as
unreliable, generating many false positive and false
Table 1 Overlap between screens
NN NC CN CC
NN 182 37 (20/42%) 45 (25/30%) 31 (17/22%)
NC — 89 25 (28/17%) 29 (33/20%)
CN — — 149 62 (42/43%)
CC — — — 144
Identical interactions found with multiple screens of different combinations.
For example, the NN and NC screens found 182 and 89 interactions,
respectively, of which 37 were identical (i.e. the protein pairs were identical),
corresponding to 20% of NN and 42% of NC interactions.
Figure 4 Interactions found with combinations of N- and C-terminal fusions. For example, 182 interactions were found with N-terminal bait
and prey fusions (blue) of which 115 were only found in this combination. 15 Interactions (largest type) were found in all four combinations and
are thus considered the most reliable. The box provides summaries of how many interactions (or percentages) were found in one, two, three, or
four combinations.
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negative results [13]. Often false positives are suspected
because many interactions are implausible and they lack
independent confirmation. However, while additional
assays such as co-immunoprecipitation can corroborate
Y2H interactions, they are often time-consuming,
expensive, and require additional reagents and protocols.
In addition, a large fraction of bona fide interactions
may be suitable for one particular assay but not for
another and thus confirmatory experiments may still
miss up to 80% of all true interactions [12]. Our results
show that permutating fusion proteins in Y2H screens
may mitigate these problems without requiring addi-
tional assays.
Further permutations of the Y2H system
Obviously many more variations of the Y2H system are
possible in addition to changing the location and nature
of fusion tags, e.g. copy number, yeast strains, reporters
etc. [1]. Other Y2H systems including commercial vec-
tors may benefit from the permutations described and
they should be used routinely in large-scale screens.
The parental vectors and the two new C-terminal vec-
tors described here are identical in most ways, including
their origins of replication (and thus their copy num-
ber), their promoters (and thus protein expression
levels), as well as the yeast strains in which they were
expressed. In addition, the experimental conditions of
our Y2H assays were identical (except for varying 3AT
concentrations). Hence, we conclude that differences in
results must result from structural constraints imposed
by the location of the DBD and AD fusion tags and the
associated sequences.
Novel VZV interactions: ORF10-ORF57
Interactions that are found in multiple permutations but
have not been reported in the literature are the most
interesting ones for follow-up studies. For space reasons
we cannot discuss all interactions that we consider as
well substantiated by multiple Y2H assays. One intri-
guing example is the interaction between ORF57 and
ORF10 which we found in all four permutations. ORF10
protein is the homologue of the herpes simplex virus
type 1 (HSV-1) VP16 protein. Both proteins have been
shown to be structural components of the virion tegu-
ment, but also appear to activate viral immediate-early
(IE) protein promoters [14]. In contrast to HSV-1,
where ORF10 is essential, VZV ORF10 is dispensable
for viral replication in vitro [15]. However, a more
detailed analysis of VZV ORF10 deletion mutants in
SCIDhu skin xenografts revealed that ORF10 is a viru-
lence factor for the pathogenesis of VZV in skin [16,17].
VZV ORF10 mutants are characterized by decreased
viral titers and decreased cutaneous lesions within skin
xenografts. Electron microscopy (EM) pictures showed
that VZV-infected epidermal cells had significantly
fewer DNA containing nucleocapsids and extensive
aggregates of intracytoplasmic viral particles [16].
Little is known about the function of the VZV ORF57
protein. This protein has been shown to localize to the
cytoplasm of infected cells and to be dispensable for the
replication of VZV in vitro [18]. However, UL3.5, the
homologue of VZV ORF57 in pseudorabies virus (PRV),
Figure 5 Reducing false negatives and false positives by
combining Y2H vectors. (A) 67 interactions from five different
herpesviruses curated from the literature ("LC”) are compared to
interactions found in this study. Shown is the fraction of these LC
interactions that are found when 1, 2, 3 or 4 vector combinations
are used. See text for more details. (B) Similar to (A), our VZV data
was compared to large-scale Y2H interactions from HSV1, mCMV,
EBV, and KSHV [4]. Shown is the fraction of interologs found by 1, 2,
3, or 4 vector combinations. See text for more details. (C) The
fraction of interactions in each combination class that is supported
by additional evidence, including literature-curated interactions,
large-scale Y2H assays, interologs, or interactions found with
alternative constructs. For example, there are 13 non-redundant
interactions that have been found in all 4 combinations (NN, NC,
CN, CC) of which 9 (= 69%) are supported by previously published
evidence or multiple (but different) constructs. See Additional file 1:
Tables S1 and S3 for details.
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has been demonstrated to be essential for virus replica-
tion in vitro, playing an important role during viral
egress. EM pictures showed that cells infected with the
PRV UL3.5 deletion mutants exhibited accumulated
intracytoplasmic viral capsids [19,20]. Deletion mutants
of VZV ORF10 and the UL3.5 homologue of VZV
ORF57 in PRV exhibit identical phenotypes, i.e. the
intracytoplasmic aggregation of viral particles, and thus
suggest that both proteins play an essential role in virus
egress. However, their precise molecular role in this
process remains to be clarified.
Our data contains a total of 15 pairs that are found in
three or four permutations but have never reported in
the literature (Additional file 1: Table S1). They should
be excellent candidates for further studies of VZV mole-
cular and structural biology.
Recommendations for future interactome screens
As a direct result from our data we recommend that
future screens should be done with a combinatin of vec-
tors. For example, mixtures of N- and C-terminal bait
plasmids could be mated with mixed N- and C-terminal
prey libraries (or arrays). As with conventional screens
bait constructs would have to be tested for auto-activa-
tion but this remains straight-forward. In order to
improve mating efficiency the four combinations (NN,
NC, CN, CC) could be mated separately and then mixed
for further selection of positives. However, for less com-
plex libraries (as those of virus genomes) this should not
be necessary. Given that other factors in addition to N-
or C-terminal fusions play a role in Y2H screens [1],
additional vectors could be added.
Conclusions
In summary, using permutations of fusion proteins has
the potential to dramatically reduce false negatives in
yeast two-hybrid screens while providing a simple way
to rank interactions qualitatively. This should signifi-
cantly improve future large-scale screens as well as
downstream analysis of selected interactions.
Methods
Literature-curated interaction data and interologs
Literature-curated interactions were derived from [4]:
First, a few VZV interactions from small-scale studies
are considered to be highly reliable as they have been
verified by additional experiments. Second, small-scale
interactions from other herpesviruses with homologs in
VZV are here considered as “literature-curated” as well.
Third, we used large-scale Y2H data from [4] and other
studies. If these interactions (in any herpesvirus different
from VZV) had homologous pairs in VZV, they were
considered as “interologs”. For example, the KSHV
interaction ORF60-ORF61 has a homologous interacting
pair in VZV, ORF18-ORF19 which is thus an interolog
of ORF60-ORF61.
Vector construction and ORF cloning
Here we describe a new set of vectors that are based on
the well-established pGBKT7 and pGADT7 vectors
(Clontech) and their Gateway derivatives pGBKT7g and
pGADT7g [21] (Figure 1). We modified the latter two
vectors by inserting the Gateway RfB cassette (for read-
ing frame B) in a way that the DBD and AD can be
fused to the C-termini of cloned proteins as opposed to
the usual N-termini and named these vectors pGBKCg
and pGADCg, respectively (Figure 2). Next, we cloned
all full-length 69 open reading frames (ORFs) as well as
18 protein fragments of Varicella-Zoster-Virus (VZV)
into pGADT7g, pGBKT7g, pGADCg, and pGBKCg
(Additional file 1: Table S4).
Yeast two-hybrid assays and quality scoring
We systematically tested all N- and C-terminal baits
against all N- and C-terminal VZV preys using standard
matrix-based Y2H protocols as described previously
[21,22]. The quality of interactions was evaluated by two
different strategies: first, we compared our interactions to
a list of known herpesviral interactions. Because not
many interactions have been detected in VZV (except in
our own studies [4,5], we used a list of herpesviral inter-
actions curated from small-scale studies [4] as a gold-
standard dataset. We considered a VZV interaction as
“LC-verified” if it had at least one interolog in this litera-
ture-curated (LC) dataset. Second, we compared our
VZV dataset to a large set of herpesviral Y2H interactions
[4], comprising interactions from KSHV, VZV, EBV,
mCMV, and HSV1. We considered a VZV interaction as
“interolog-verified” if it had at least one interolog in one
of the four non-VZV viruses (as VZV interactions would
not be interologs). This logic is based on the idea that
interactions are conserved and that multiple interologs
support an interaction [23-25]. All interactions, intero-
logs, and literature-curated interactions are available as
Additional file 1: Tables S1-3 and from [4].
Additional file 1: Table S1. Y2H data - all interactions described in
this paper. A detailed legend is included in the Excel spreadsheet. The
protein interactions from this publication have been submitted to the
IMEx http://imex.sf.net consortium through IntAct (pmid: 17145710) and
assigned the identifier IM-11718. The dataset is available at http://www.
ebi.ac.uk/intact/search/do/search?searchString=IM-11718. Table S2. All
PPIs - interactions of this study combined with all previously published
interactions among herpesviral proteins. Table S3. Verifications. A.
Permutations and contribution to interaction data. B. Verification by
additional evidence. C. All permutations seem to be created equal. This
table also contains more detailed explanations. Table S4. All VZV proteins
and fragments used in this study.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1477-5956-8-8-
S1.XLS ]
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